Literature DB >> 2128404

Lipid metabolism and signal transduction in endothelial cells.

R E Whatley1, G A Zimmerman, T M McIntyre, S M Prescott.   

Abstract

Endothelial cells have the capacity to metabolize several important lipids; this includes the ability to store and then metabolize arachidonate, as well as the capacity to synthesize platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine). Arachidonate is predominantly metabolized via cyclooxygenase to PGI2 although the spectrum of prostaglandins may vary depending upon the source of the endothelial cell. Biosynthesis of eicosanoids and PAF are likely to be an important physiologic function of the endothelial cell as these potent lipids appear to have a role in maintaining vascular tone and mediating interactions of the endothelium with circulating inflammatory cells. In addition to production of eicosanoids and PAF, endothelial cells metabolize exogenous arachidonate and arachidonate metabolites and other fatty acids such as linoleate to bioactive compounds (HODEs). There is also evidence that small amounts of arachidonate are metabolized via a lipoxygenase. The physiologic significance of these minor lipid pathways is not known at this time. Production of eicosanoids and PAF is not a constitutive function of the endothelial cell. Lipid biosynthesis by endothelial cells is one component of the early activation response that occurs in response to stimulation with pro-inflammatory and vasoactive hormones or to pathologic agents such as oxidants and bacterial toxins. A central mechanism for activation of the relevant pathways is a rise in cellular calcium concentrations that can be mediated by hormone-receptor-binding or by direct permeabilization of the cell membrane to calcium (Fig. 3). Regulatory mechanisms distal to the calcium signal are unknown, but current evidence suggests that calcium directly or indirectly activates phospholipases that release arachidonate from phospholipids and hydrolyze a specific phospholipid to the immediate precursor of PAF. There is evidence that protein kinase C may, in part, regulate this process, but the role of other potential regulatory components, such as other protein kinases or G-proteins is not known. As noted above, the most direct mechanism for initiation of PAF biosynthesis and arachidonate release would be activation of a phospholipase A2 as shown in Fig. 3. Activation of other phospholipases (e.g. phospholipase C) may contribute to the total amount of arachidonate released, although the magnitude of that contribution is not yet known. In addition to generation of PAF and eicosanoids, activation of endothelial cell phospholipases generates second messengers that are important in intracellular signaling (Fig. 4). Activation of phospholipase C, in response to hormonal stimulation, generates diacylglycerol and inositol phosphates from phosphatidylinositol. Each of these is a potent intracellular second messenger.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2128404     DOI: 10.1016/0163-7827(90)90005-6

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  15 in total

1.  Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.

Authors:  J Mateo; M T Miras-Portugal; E Castro
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Rickettsial stimulation of endothelial platelet-activating factor synthesis.

Authors:  T S Walker; G E Mellott
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

3.  Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells.

Authors:  M Bunting; D E Lorant; A E Bryant; G A Zimmerman; T M McIntyre; D L Stevens; S M Prescott
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Activation of group VI phospholipase A2 isoforms in cardiac endothelial cells.

Authors:  Janhavi Sharma; John Turk; David J Mancuso; Harold F Sims; Richard W Gross; Jane McHowat
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-29       Impact factor: 4.249

Review 5.  Stroke and T-cells.

Authors:  Thiruma V Arumugam; D Neil Granger; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

6.  Proliferation-dependent changes in release of arachidonic acid from endothelial cells.

Authors:  R E Whatley; K Satoh; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 7.  Lipid metabolism of myocardial endothelial cells.

Authors:  K Schoonderwoerd; H Stam
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

8.  Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition.

Authors:  Daisuke Ogasawara; Hui Deng; Andreu Viader; Marc P Baggelaar; Arjen Breman; Hans den Dulk; Adrianus M C H van den Nieuwendijk; Adriann M C H van den Nieuwendijk; Marjolein Soethoudt; Tom van der Wel; Juan Zhou; Herman S Overkleeft; Manuel Sanchez-Alavez; Simone Mori; Simone Mo; William Nguyen; Bruno Conti; Xiaojie Liu; Yao Chen; Qing-Song Liu; Benjamin F Cravatt; Mario van der Stelt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-14       Impact factor: 11.205

9.  Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2.

Authors:  P Xia; R M Kramer; G L King
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

Review 10.  The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression.

Authors:  J M Houthuijzen; L G M Daenen; J M L Roodhart; E E Voest
Journal:  Br J Cancer       Date:  2012-05-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.